Tchaikapharma High Quality Medicines AD
THQM | BSOBGN
Overview
Corporate Details
- ISIN(s):
- BG1100008074
- LEI:
- 5299003VDHTK75D1JE38
- Country:
- Bulgaria
- Address:
- бул./ул. бул. Г.М.ДИМИТРОВ № 1, 1172 София
- Website:
- https://tchaikapharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Tchaikapharma High Quality Medicines AD is a pharmaceutical company engaged in the development, manufacturing, and commercialization of a broad range of high-quality medicines. The company's core expertise lies in producing generic and in-licensed pharmaceuticals, with a specialization in complex generics (polypills). It focuses on providing affordable, cost-effective treatments for socially significant diseases across various therapeutic areas, including cardiovascular, nervous system, metabolic, and anti-inflammatory conditions. Tchaikapharma is committed to adhering to and exceeding international manufacturing standards to improve access to contemporary and effective therapies for patients and healthcare professionals.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Tchaikapharma High Quality Medicines AD.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2024-04-15 23:00 |
Annual / Quarterly Financial Statement
5299003VDHTK75D1JE38-20231231-BG-CON_CALCULATION-RES.html
|
English | 47.8 KB | |
| 2024-04-15 23:00 |
Annual / Quarterly Financial Statement
609557-7TH_2023 CONS_BG_signed.xls
|
Bulgarian | 719.5 KB | |
| 2024-04-15 23:00 |
Annual / Quarterly Financial Statement
609559-7TH_2023 CONS_EN_signed.xls
|
Bulgarian | 235.0 KB | |
| 2024-04-15 23:00 |
Annual Report (ESEF)
609558-5299003VDHTK75D1JE38-20231231-EN-CON.zip
|
Bulgarian | 6.4 MB | |
| 2024-03-26 23:00 |
Interim Report
608037-SPRAVKA_1_IND_GFO_6M.xls
|
Bulgarian | 722.0 KB | |
| 2024-03-26 23:00 |
Management Discussion and Analysis
5299003VDHTK75D1JE38-20231231-BG-SEP.xhtml
|
Bulgarian | 21.8 MB | |
| 2023-07-12 23:00 |
Regulatory News Service
7TH_2022 CONS_BG.xls
|
Bulgarian | 718.0 KB | |
| 2023-06-07 23:00 |
Interim Report
SPRAVKA_1_IND_GFO_6M_signed.xls
|
Bulgarian | 778.5 KB | |
| 2023-06-07 23:00 |
Annual Report
5299003VDHTK75D1JE38-20221231-BG-SEP.xhtml
|
Bulgarian | 37.0 MB | |
| 2022-07-26 23:00 |
Annual / Quarterly Financial Statement
5299003VDHTK75D1JE38-20211231-BG-SEP.xhtml
|
Bulgarian | 5.7 MB | |
| 2022-07-26 23:00 |
Annual / Quarterly Financial Statement
7TH_2021_signed.xls
|
Bulgarian | 939.0 KB | |
| 2022-07-26 23:00 |
Annual Report (ESEF)
5299003VDHTK75D1JE38-20211231-BG-CON.zip
|
Bulgarian | 3.2 MB | |
| 2022-07-26 23:00 |
Annual / Quarterly Financial Statement
7TH_2021 CONS.xls
|
Bulgarian | 900.0 KB |
Automate Your Workflow. Get a real-time feed of all Tchaikapharma High Quality Medicines AD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Tchaikapharma High Quality Medicines AD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
/other/Diamyd_Medical_AB_publ-logo.png){kind=logo}
